Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2).
J Addict Med
; 14(4): e1-e3, 2020.
Article
in En
| MEDLINE
| ID: mdl-32412931
ABSTRACT
The COVID-19 health crisis joined, rather than supplanted, the opioid crisis as the most acutely pressing threats to US public health. In the setting of COVID-19, opioid use disorder treatment paradigms are being disrupted, including the fact that methadone clinics are scrambling to give "take-home" doses where they would typically not. The rapid transition away from in-person examination, dosing and group therapy in an era of social isolation calls for adjustments to clinical practice, including emphasizing patient-provider communication, favoring new inductees on buprenorphine and leveraging technology to optimize safety of medication treatment.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Infection Control
/
Coronavirus Infections
/
Substance Abuse Treatment Centers
/
Opiate Substitution Treatment
/
Pandemics
/
Narcotic Antagonists
/
Opioid-Related Disorders
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
J Addict Med
Year:
2020
Document type:
Article